Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro
- 1 January 2007
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 73 (1) , 78-83
- https://doi.org/10.1016/j.antiviral.2006.07.009
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Novel Nonnucleoside Inhibitor of Hepatitis C Virus RNA-Dependent RNA PolymeraseAntimicrobial Agents and Chemotherapy, 2004
- Discovery of Pyrano[3,4-b]indoles as Potent and Selective HCV NS5B Polymerase InhibitorsJournal of Medicinal Chemistry, 2004
- Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patientsGastroenterology, 2004
- Structure-based design of inhibitors of NS3 serine protease of hepatitis C virusJournal of Molecular Graphics and Modelling, 2004
- Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymeraseAntiviral Research, 2003
- Optimal therapy of hepatitis CHepatology, 2002
- Identification and Biological Characterization of Heterocyclic Inhibitors of the Hepatitis C Virus RNA-dependent RNA PolymeraseJournal of Biological Chemistry, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- COMBINATION TREATMENT WITH INTERFERON AND RIBAVIRIN FOR CHRONIC HEPATITIS CClinics in Liver Disease, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis CNew England Journal of Medicine, 1998